These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34399038)

  • 21. Human gingiva-derived mesenchymal stem cells alleviate inflammatory bowel disease via IL-10 signalling-dependent modulation of immune cells.
    Lu Y; Xu Y; Zhang S; Gao J; Gan X; Zheng J; Lu L; Zeng W; Gu J
    Scand J Immunol; 2019 Sep; 90(3):e12751. PubMed ID: 30664802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-23 in inflammatory bowel diseases and colon cancer.
    Neurath MF
    Cytokine Growth Factor Rev; 2019 Feb; 45():1-8. PubMed ID: 30563755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-mouse CD52 monoclonal antibody ameliorates intestinal epithelial barrier function in interleukin-10 knockout mice with spontaneous chronic colitis.
    Wang H; Dong J; Shi P; Liu J; Zuo L; Li Y; Gong J; Gu L; Zhao J; Zhang L; Zhang W; Zhu W; Li N; Li J
    Immunology; 2015 Feb; 144(2):254-62. PubMed ID: 25087772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired IL-10 Receptor-mediated Suppression in Monocyte From Patients With Crohn Disease.
    Nunberg MY; Werner L; Kopylov U; Haberman Y; Lahad A; Weiss B; Shouval DS
    J Pediatr Gastroenterol Nutr; 2018 May; 66(5):779-784. PubMed ID: 29045353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function.
    Shouval DS; Biswas A; Goettel JA; McCann K; Conaway E; Redhu NS; Mascanfroni ID; Al Adham Z; Lavoie S; Ibourk M; Nguyen DD; Samsom JN; Escher JC; Somech R; Weiss B; Beier R; Conklin LS; Ebens CL; Santos FG; Ferreira AR; Sherlock M; Bhan AK; Müller W; Mora JR; Quintana FJ; Klein C; Muise AM; Horwitz BH; Snapper SB
    Immunity; 2014 May; 40(5):706-19. PubMed ID: 24792912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. INTERACTIONS AMONG INTERLEUKIN-6, C-REACTIVE PROTEIN AND INTERLEUKIN-6 (-174) G/C POLYMORPHISM IN THE PATHOGENESIS OF CROHN'S DISEASE AND ULCERATIVE COLITIS.
    Takač B; Mihaljević S; Glavaš-Obrovac L; Kibel A; Suver-Stević M; Canecki-Varžić S; Samardžija M; Rajkovac I; Kovač D; Štefanić M
    Acta Clin Croat; 2020 Mar; 59(1):67-80. PubMed ID: 32724277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating intestinal inflammation in DSS-induced model of IBD.
    Kim JJ; Shajib MS; Manocha MM; Khan WI
    J Vis Exp; 2012 Feb; (60):. PubMed ID: 22331082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
    Li Y; Chen J; Bolinger AA; Chen H; Liu Z; Cong Y; Brasier AR; Pinchuk IV; Tian B; Zhou J
    Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S38-S62. PubMed ID: 34791293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbiota-inducible Innate Immune, Siderophore Binding Protein Lipocalin 2 is Critical for Intestinal Homeostasis.
    Singh V; Yeoh BS; Chassaing B; Zhang B; Saha P; Xiao X; Awasthi D; Shashidharamurthy R; Dikshit M; Gewirtz A; Vijay-Kumar M
    Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):482-498.e6. PubMed ID: 27458605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
    Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
    Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-interleukin 10 receptor monoclonal antibody is an adjuvant for T helper cell type 1 responses to soluble antigen only in the presence of lipopolysaccharide.
    Castro AG; Neighbors M; Hurst SD; Zonin F; Silva RA; Murphy E; Liu YJ; O'Garra A
    J Exp Med; 2000 Nov; 192(10):1529-34. PubMed ID: 11085755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.
    Duchmann R; Schmitt E; Knolle P; Meyer zum Büschenfelde KH; Neurath M
    Eur J Immunol; 1996 Apr; 26(4):934-8. PubMed ID: 8625991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation.
    Scheibe K; Kersten C; Schmied A; Vieth M; Primbs T; Carlé B; Knieling F; Claussen J; Klimowicz AC; Zheng J; Baum P; Meyer S; Schürmann S; Friedrich O; Waldner MJ; Rath T; Wirtz S; Kollias G; Ekici AB; Atreya R; Raymond EL; Mbow ML; Neurath MF; Neufert C
    Gastroenterology; 2019 Mar; 156(4):1082-1097.e11. PubMed ID: 30452921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An antibiotic-responsive mouse model of fulminant ulcerative colitis.
    Kang SS; Bloom SM; Norian LA; Geske MJ; Flavell RA; Stappenbeck TS; Allen PM
    PLoS Med; 2008 Mar; 5(3):e41. PubMed ID: 18318596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease.
    Hohenberger M; Cardwell LA; Oussedik E; Feldman SR
    J Dermatolog Treat; 2018 Feb; 29(1):13-18. PubMed ID: 28521565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic characteristics and clinical manifestations of inflammatory bowel disease in infants and children under 2 years of age in Liaoning Province, China: five of six infants with IL-10R mutations.
    Teng X; Xu L; Sun M; Guo J
    Paediatr Int Child Health; 2019 Feb; 39(1):59-64. PubMed ID: 30900524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IRF4 regulates IL-17A promoter activity and controls RORγt-dependent Th17 colitis in vivo.
    Mudter J; Yu J; Zufferey C; Brüstle A; Wirtz S; Weigmann B; Hoffman A; Schenk M; Galle PR; Lehr HA; Mueller C; Lohoff M; Neurath MF
    Inflamm Bowel Dis; 2011 Jun; 17(6):1343-58. PubMed ID: 21305677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis.
    Kullberg MC; Jankovic D; Feng CG; Hue S; Gorelick PL; McKenzie BS; Cua DJ; Powrie F; Cheever AW; Maloy KJ; Sher A
    J Exp Med; 2006 Oct; 203(11):2485-94. PubMed ID: 17030948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allergic and Immunologic Perspectives of Inflammatory Bowel Disease.
    Clarke K; Chintanaboina J
    Clin Rev Allergy Immunol; 2019 Oct; 57(2):179-193. PubMed ID: 29754190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.